- NEWS
COVID vaccines have higher approval in less-affluent countries
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-01987-9
References
Solís Arce, J. S. et al. Nature Med. https://doi.org/10.1038/s41591-021-01454-y (2021).
COVID vaccines to reach poorest countries in 2023 — despite recent pledges
Six months of COVID vaccines: what 1.7 billion doses have taught scientists
WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic
How COVID is changing the study of human behaviour